JP2021515005A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021515005A5 JP2021515005A5 JP2020545532A JP2020545532A JP2021515005A5 JP 2021515005 A5 JP2021515005 A5 JP 2021515005A5 JP 2020545532 A JP2020545532 A JP 2020545532A JP 2020545532 A JP2020545532 A JP 2020545532A JP 2021515005 A5 JP2021515005 A5 JP 2021515005A5
- Authority
- JP
- Japan
- Prior art keywords
- oxytocin peptide
- labeled
- composition
- labeled oxytocin
- oxytocin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024009405A JP2024038482A (ja) | 2018-03-01 | 2024-01-25 | 標識オキシトシンならびに製造および使用の方法 |
| JP2025230634A JP2026035830A (ja) | 2018-03-01 | 2025-12-04 | 標識オキシトシンならびに製造および使用の方法 |
| JP2025230635A JP2026035831A (ja) | 2018-03-01 | 2025-12-04 | 標識オキシトシンならびに製造および使用の方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862637187P | 2018-03-01 | 2018-03-01 | |
| US62/637,187 | 2018-03-01 | ||
| PCT/US2019/020419 WO2019169342A1 (en) | 2018-03-01 | 2019-03-01 | Labeled oxytocin and method of manufacture and use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024009405A Division JP2024038482A (ja) | 2018-03-01 | 2024-01-25 | 標識オキシトシンならびに製造および使用の方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021515005A JP2021515005A (ja) | 2021-06-17 |
| JP2021515005A5 true JP2021515005A5 (enExample) | 2022-03-07 |
Family
ID=65763911
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020545532A Pending JP2021515005A (ja) | 2018-03-01 | 2019-03-01 | 標識オキシトシンならびに製造および使用の方法 |
| JP2024009405A Withdrawn JP2024038482A (ja) | 2018-03-01 | 2024-01-25 | 標識オキシトシンならびに製造および使用の方法 |
| JP2025230635A Pending JP2026035831A (ja) | 2018-03-01 | 2025-12-04 | 標識オキシトシンならびに製造および使用の方法 |
| JP2025230634A Pending JP2026035830A (ja) | 2018-03-01 | 2025-12-04 | 標識オキシトシンならびに製造および使用の方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024009405A Withdrawn JP2024038482A (ja) | 2018-03-01 | 2024-01-25 | 標識オキシトシンならびに製造および使用の方法 |
| JP2025230635A Pending JP2026035831A (ja) | 2018-03-01 | 2025-12-04 | 標識オキシトシンならびに製造および使用の方法 |
| JP2025230634A Pending JP2026035830A (ja) | 2018-03-01 | 2025-12-04 | 標識オキシトシンならびに製造および使用の方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US11970554B2 (enExample) |
| EP (1) | EP3759121A1 (enExample) |
| JP (4) | JP2021515005A (enExample) |
| WO (1) | WO2019169342A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019169342A1 (en) * | 2018-03-01 | 2019-09-06 | Trigemina, Inc. | Labeled oxytocin and method of manufacture and use |
| US11935238B2 (en) * | 2021-12-22 | 2024-03-19 | RealizeMD Ltd. | Systems and methods for generating clinically relevant images that preserve physical attributes of humans while protecting personal identity |
| US11631208B1 (en) * | 2021-12-22 | 2023-04-18 | RealizeMD Ltd. | Systems and methods for generating clinically relevant images that preserve physical attributes of humans while protecting personal identity |
| US12440454B2 (en) | 2022-02-01 | 2025-10-14 | Portland Technology Holdings Llc | Pharmaceutical compositions containing hemp extract for administration to felines and related methods |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1936364A (en) | 1930-08-22 | 1933-11-21 | Pfizer Charles & Co | Citrate solutions |
| US2260004A (en) | 1939-11-03 | 1941-10-21 | Pfizer Charles & Co | Stable soluble magnesium acid citrate |
| US2938891A (en) | 1956-03-30 | 1960-05-31 | Roussel Uclaf | Method of making oxytocin and intermediates thereof |
| US3076797A (en) | 1957-07-22 | 1963-02-05 | Roussel Uclaf | Process of producing oxytocin and intermediates obtained thereby |
| DE19627228A1 (de) | 1996-07-05 | 1998-01-08 | Pfeiffer Erich Gmbh & Co Kg | Austragvorrichtung für Medien |
| GB0209494D0 (en) | 2002-04-25 | 2002-06-05 | Optinose As | Nasal devices |
| JP2004161664A (ja) * | 2002-11-13 | 2004-06-10 | Fancl Corp | プロポリス組成物 |
| WO2004062563A2 (en) | 2003-01-16 | 2004-07-29 | Université de Lausanne | Methods for screening for therapeutic agents that are useful in the treatment of oxytocin and vasopressin-related disorders |
| GB0319119D0 (en) | 2003-08-14 | 2003-09-17 | Optinose As | Delivery devices |
| US7763234B2 (en) | 2004-03-04 | 2010-07-27 | Ge Healthcare As | Pharmaceutical compounds |
| CA2580464A1 (en) | 2004-09-29 | 2006-04-06 | Ge Healthcare As | Urokinase plasminogen activator receptor targeted contrast agent |
| US20100311655A1 (en) * | 2007-06-07 | 2010-12-09 | Mdrna, Inc. | Intranasal carbetocin formulations and methods for the treatment of autism |
| JP2010085108A (ja) * | 2008-09-29 | 2010-04-15 | Nano Factory:Kk | 生体光イメージング用プローブ |
| US20120093725A1 (en) | 2009-04-10 | 2012-04-19 | Inserm (Institut National De La Sante Et De La Recherche Medicale | Fucoidans as Ligands for the Diagnosis of Degenerative Pathologies |
| WO2011106732A1 (en) | 2010-02-25 | 2011-09-01 | Wyeth Llc | Pet monitoring of ab-directed immunotherapy |
| US20130130985A1 (en) | 2010-04-01 | 2013-05-23 | Paul Alewood | Oxytocin peptide analogues |
| JP2013230986A (ja) * | 2010-08-25 | 2013-11-14 | Kyorin Pharmaceutical Co Ltd | 新規ヒダントイン誘導体及びそれらを有効成分とする医薬 |
| JO3400B1 (ar) | 2010-09-30 | 2019-10-20 | Ferring Bv | مركب صيدلاني من كاربيتوسين |
| JP6445861B2 (ja) | 2014-12-18 | 2018-12-26 | 国立大学法人金沢大学 | オキシトシン検出のためのサンプルの前処理方法 |
| US11389473B2 (en) * | 2015-01-07 | 2022-07-19 | Tonix Pharmaceuticals Holding Corp. | Magnesium-containing oxytocin formulations and methods of use |
| CN108697756B (zh) | 2015-12-02 | 2022-05-27 | 密歇根大学董事会 | Her2肽试剂和方法 |
| WO2019169342A1 (en) * | 2018-03-01 | 2019-09-06 | Trigemina, Inc. | Labeled oxytocin and method of manufacture and use |
-
2019
- 2019-03-01 WO PCT/US2019/020419 patent/WO2019169342A1/en not_active Ceased
- 2019-03-01 JP JP2020545532A patent/JP2021515005A/ja active Pending
- 2019-03-01 US US16/976,912 patent/US11970554B2/en active Active
- 2019-03-01 EP EP19710979.6A patent/EP3759121A1/en active Pending
-
2024
- 2024-01-25 JP JP2024009405A patent/JP2024038482A/ja not_active Withdrawn
- 2024-03-29 US US18/621,985 patent/US12466855B2/en active Active
-
2025
- 2025-12-04 JP JP2025230635A patent/JP2026035831A/ja active Pending
- 2025-12-04 JP JP2025230634A patent/JP2026035830A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6594487B2 (ja) | 抗ウイルス化合物の合成 | |
| CN104812384B (zh) | 二取代的氨基酸及其制备和使用方法 | |
| JP3271259B2 (ja) | 改良された放射性標識 | |
| Van Staveren et al. | Conjugation of a novel histidine derivative to biomolecules and labelling with [99m Tc (OH 2) 3 (CO) 3]+ | |
| EP3131585B1 (en) | Multidentate bifunctional chelating agents for radionuclide complexation in diagnostics and therapy | |
| JP2021532784A5 (enExample) | ||
| JP2006528644A5 (enExample) | ||
| US20180179175A1 (en) | Processes for preparing antiviral compounds | |
| JP5705434B2 (ja) | キレート剤 | |
| US10927132B2 (en) | Transmetalation methods for the synthesis of PET and SPECT imaging agents | |
| JP2010503618A5 (enExample) | ||
| CN105848687B (zh) | 放射性示踪剂组合物和方法 | |
| JP2007514752A5 (enExample) | ||
| WO2013081091A1 (ja) | 非特異的腎集積が低減された放射性標識ポリペプチド作製用薬剤 | |
| JP2017502946A5 (enExample) | ||
| JP5750209B2 (ja) | 機能性分子、機能性分子合成用アミダイド、及び標的物質解析方法 | |
| AU2007304508A1 (en) | Silicon derivatives for pet imaging | |
| JP6067580B2 (ja) | オキシム連結反応の放射性安定化におけるアニリンの使用 | |
| AU2018298658B2 (en) | Improved process for preparing imetelstat | |
| EP1908472A1 (en) | Silicon derivatives for PET imaging | |
| KR20240008341A (ko) | 방사성약제학적 소마토스타틴 수용체 리간드 및 그의 전구체 | |
| Chapleur et al. | Toward imaging glycotools by click coupling | |
| US12344625B2 (en) | Process for preparing rhenium chelated MAG3 oligonucleotides | |
| Kriek et al. | Chemical synthesis of picornaviral protein primers of RNA replication | |
| RU2795447C1 (ru) | Способ получения конъюгата boc-thz-phe-d-trp-lys(boc)-thr-nhch2ch2nh-dota, являющегося прекурсором для противоопухолевых радиофармпрепаратов |